The independent source for health policy research, polling, and news.
1,081-1,100 of 113,253 results
FDA-approved GLP-1 medications, in both injectable and pill form, will be available with a $50 monthly co-pay to beneficiaries enrolled in Medicare Part D or a Medicare Advantage plan with drug coverage. The pilot program will start in July and run through 2027.
AP reported that the State Department program to revoke passports for about 2,700 Americans who owe $100,000 or more in child support will begin today. That figure will soon expand to include those who owe $2,500 or more.
The cruise ship MV Hondius is scheduled to arrive in the Canary Islands on Sunday, where it will anchor offshore and allow passengers wearing hazmat gear to transfer by boat to the port, ABC News reported. Back in the U.S., two more states — Virginia and Texas — are monitoring former passengers from the ship. Plus: The CDC official in charge of monitoring public health on cruise ships has stepped down.
Today's early morning highlights from the major news organizations.
Editorial writers delve into these public health issues.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
People who live in and around Calhoun, Georgia, say the levels of "forever chemicals" in their bodies are higher than what national health guidelines consider safe. Some have been diagnosed with liver and thyroid conditions or cancer. Scientists have warned for decades about the risks, but Georgia’s Environmental Protection Division did little to confront the problem, The Atlanta Journal-Constitution, AP, and FRONTLINE (PBS) found.
The Santa Clara Medical Center and medical office building are operating normally as additional water treatment measures are implemented. More news is on potential hospital closures in Minnesota and Pennsylvania; AI integration into healthcare; and more.
ProPublica reports on how officers have escalated the use of the chemicals throughout recent anti-immigration initiatives, causing harm to at least 79 children across the country in the process. The Department of Homeland Security says parents are to blame for any harm caused.
Eli Lilly's diabetes drug Mounjaro brought in nearly $9 billion in the first quarter of 2026, surpassing the nearly $8 billion in sales for Merck's Keytruda, a cancer therapy.
Tofersen targets a small subset of patients with a specific genetic form of amyotrophic lateral sclerosis, also called Lou Gehrig’s disease. The New York Times reports that new study results— in which some patients improved and others did not get worse — are generating hope for the usually fatal disease.
As of Wednesday, at least three states — Georgia, California, and Arizona — are monitoring residents who previously disembarked from the MV Hondius cruise ship. At this time, none of the former passengers are showing signs of illness.
Today's early morning highlights from the major news organizations.
Opinion writers tackle these public health issues.
The settlement comes after the makers were accused of using a monopoly to increase prices, requiring injectors to be purchased in a two-pack, and restricting generic versions of the EpiPen.
Physicians are calling for stricter laws governing AI in the wake of a slew of deepfake videos circulating on social media. Doctors worry that it could contribute to the ongoing erosion of public trust in the medical establishment, and even to insurance fraud, Axios reports.
If the Supreme Court rules that mifepristone can't be prescribed via telehealth or dispensed by mail, providers say, misoprostol alone has been found to be a safe and effective method for ending pregnancies. Some countries already rely on misoprostol for abortion care.
Health officials in South Africa confirmed the findings. Meanwhile, a battle over where to dock the MV Hondius continued Wednesday morning.
The move marks a shift after years of efforts by the FDA to regulate flavored vapes and just after The Wall Street Journal reported that President Donald Trump pushed for the approval, The Washington Post reports.
© 2026 KFF